Why DocuSign Stock Is Plummeting This Week

Key Points

• Shares of DocuSign dropped this week after OpenAI released a new competitor in the space, DocuGPT.

• DocuGPT and DocuSign will have many similar capabilities.

• However, DocuSign has years' worth of relationships and trust built up with its customers and partners.

• 10 stocks we like better than Docusign ›

Shares of leading e-signature and agreement management platform DocuSign (NASDAQ: DOCU) are down 16% this week as of noon ET on Thursday, according to data provided by S&P Global Market Intelligence.

This decline stems from artificial intelligence behemoth OpenAI launching DocuGPT -- an AI solution with similar capabilities to DocuSign -- on Tuesday.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

Experiencing most software stocks' worst nightmare, DocuSign saw its shares plummet this week. However, I don't believe it is necessarily a death knell for the well-established firm.

Image source: Getty Images.

DocuSign: A true battleground stock

On one hand, OpenAI's release of DocuGPT instantly creates a viable competitor for e-signatures and the broader contract (or agreement) process as a whole -- DocuSign's exact niche.

On the other hand, saying DocuSign has deeply entrenched itself in its niche is almost an understatement. Used by 95% of the Fortune 500, DocuSign has more than 1.7 million customers and over 1 billion users.

Thanks to this massive customer base -- and the company's partner ecosystem that includes almost every big tech company (minus OpenAI at this point, I'm guessing) -- DocuSign has years' worth of relationships and trust built up with its allies.

That won't be shaken up overnight by DocuGPT.

That said, DocuGPT isn't just trying to disrupt the e-signature niche, but is coming right after DocuSign's Intelligent Agreement Management (IAM) platform, which was supposed to be its next wave of growth.

Offering more intuitive solutions like obligation management, workflow automation, agreement preparation, AI-assisted review, and renewal management, the IAM platform's capabilities now have direct competition from DocuGPT.

While DocuSign won't immediately fade into obscurity, I'd rather watch from the sidelines due to this threat of AI disruption and the company's immense stock-based compensation, which equals 20% of sales.

Should you invest $1,000 in Docusign right now?

Before you buy stock in Docusign, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Docusign wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $631,456!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,147,755!*

Now, it’s worth noting Stock Advisor’s total average return is 1,064% — a market-crushing outperformance compared to 191% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of September 29, 2025

Josh Kohn-Lindquist has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Docusign. The Motley Fool has a disclosure policy.